Bilirubin-Induced Neurotoxicity in the Preterm Neonate

Jon F Watchko1

  • 1Division of Newborn Medicine, Department of Pediatrics, Magee-Womens Hospital, Children's Hospital of Pittsburgh, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, 300 Halket Street, Pittsburgh, PA 15213, USA.

Insights

Bilirubin neurotoxicity poses risks to preterm infants due to immature brains. Even low bilirubin levels can cause kernicterus, especially with low albumin, highlighting the need for vigilance in neonatal care.

Area of Science:

  • Neonatal Medicine
  • Neuroscience
  • Toxicology

Background:

  • Bilirubin-induced neurotoxicity is a significant concern in preterm neonates.
  • Multiple pathways, including oxidative stress and neuroinflammation, contribute to neuronal injury.
  • Preterm infants' immature central nervous systems increase vulnerability.

Purpose of the Study:

  • To review the mechanisms of bilirubin neurotoxicity in preterm neonates.
  • To highlight the clinical manifestations and risk factors for bilirubin-induced brain injury.
  • To emphasize the continued occurrence of kernicterus even at lower bilirubin levels.

Main Methods:

  • Literature review of cellular and molecular mechanisms.
  • Analysis of clinical presentations of acute bilirubin encephalopathy.
  • Examination of factors contributing to kernicterus in preterm infants.

Main Results:

  • Bilirubin toxicity involves plasma membrane damage, excitotoxicity, neuroinflammation, oxidative stress, and cell cycle arrest.
  • Acute bilirubin encephalopathy can present subtly as recurrent apnea.
  • Low-bilirubin kernicterus is reported in preterm neonates, often linked to hypoalbuminemia.

Conclusions:

  • Preterm neonates are uniquely susceptible to bilirubin neurotoxicity.
  • Understanding the multifactorial nature of bilirubin injury is crucial for prevention and management.
  • Hypoalbuminemia is a key factor in low-bilirubin kernicterus, necessitating careful monitoring.